Resultados del tratamiento
del cáncer de mama, Programa
Nacional de Cáncer del Adulto
Author
dc.contributor.author
Castillo, César del
Author
dc.contributor.author
Cabrera C., M. Elena
Author
dc.contributor.author
Derio P., Lea
Author
dc.contributor.author
Gaete V., Fancy
Author
dc.contributor.author
Cavada Chacón, Gabriel
Admission date
dc.date.accessioned
2019-03-18T12:02:06Z
Available date
dc.date.available
2019-03-18T12:02:06Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Rev Med Chile 2017; 145: 1507-1513
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.other
10.4067/s0034-98872017001201507
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/167426
Abstract
dc.description.abstract
Background: Breast cancer is the most common malignant tumor in women
in the world. In 2005, it was incorporated to the Explicit Guaranties Health
System (GES) in Chile. Aim: To describe the demographic and clinical characteristics
of breast cancer patients and to determine the effect of incorporating
these women to GES. Material and Methods: Medical records of 5,119 women
with breast cancer aged 59 ± 14 years, attended at six public hospitals between
2000 and 2010 were reviewed. Median follow up was 87 months (range 1-182).
Mortality was assessed using death certificates obtained at the National Identification
Registry. Results: Sixty six percent of women were in stage I-II, 29% in
stage III and 5% in stage IV. Surgery was performed in 4023/5119 cases (79%),
adyuvant radiotherapy in 3627/4517 cases (80%), chemotherapy in 3,204/3,424
cases (94%) and hormone therapy in 1,695/2,375 cases (71%). Between 2000
and 2010, there was a significant increase in the proportion of cases in stage I,
from 8% to 25%, (p < 0.01). Overall survival (OS) increased 1% per year, since
the beginning of GES system (p = 0.024). Five year OS was 75.1%. The figures
for Stage I, II, III and IV were 93, 84, 62 and 27% respectively (p < 0.01). Patients
without lymph node involvement and who were not triple negative, had a
significantly better OS. Conclusions: There was a significant increase in stage I
cases, and a 1% per year OS improvement after GES system started, compared
with the previous period.